Sungkyunkwan University · Biochemistry, Genetics and Molecular Biology
Professor Jai Min Ryu's research lab specializes in breast cancer surgery and oncology, with a focus on improving surgical outcomes and prognostic prediction in early-stage and young-onset breast cancer. The lab investigates minimally invasive surgical techniques such as RANSM and NSM, evaluates biomarkers like CA15-3 and PR levels for risk stratification, and explores adjuvant therapies like IBR following tumor-modifying surgery. Their work bridges clinical practice with translational research to enhance personalized treatment strategies.
Figures are computed from collected data and may differ slightly.
This was the first report of RANSM conducted in the KoREa-BSG. RANSM is technically feasible and acceptable with a short learning curve. Further prospective research to evaluate surgical and oncologic outcomes is needed.
The results of the present study demonstrated that elevation of CA15-3 in patients with early BC and initial normal serum CA15-3 levels has a prognostic impact.
Our results suggest that NSM can be a feasible treatment option when the intraoperative frozen biopsy is negative for tumor cells even with a TND <2.0 cm in MRI.
Our results suggest that IBR following TM is a feasible treatment option for patients with breast cancer.
ClinicalTrials.gov Identifier NCT04585074. Registered April 8, 2020.
Low PR might be a prognostic factor of ER-positive/HER2-negative in YBC.
ClinicalTrials.gov Identifier: NCT04993625. Registered on August 6, 2021. Clinical Research Information Service Identifier: KCT0006371. Registered on July 22, 2021.
Open papers in the app to read, cite, and organize with AI.
